British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma
Name:
37770126.pdf
Size:
1.719Mb
Format:
PDF
Description:
Identified with Open Access button
Authors
Rushbrook, S. M.Kendall, T. J.
Zen, Y.
Albazaz, R.
Manoharan, Prakash
Pereira, S. P.
Sturgess, R.
Davidson, B. R.
Malik, H. Z.
Manas, D.
Heaton, N.
Prasad, K. R.
Bridgewater, J.
Valle, Juan W
Goody, R.
Hawkins, M.
Prentice, W.
Morement, H.
Walmsley, M.
Khan, S. A.
Affiliation
Department of Hepatology, Norfolk and Norwich University Hospitals NHS Trust, Norwich, UKIssue Date
2023
Metadata
Show full item recordAbstract
These guidelines for the diagnosis and management of cholangiocarcinoma (CCA) were commissioned by the British Society of Gastroenterology liver section. The guideline writing committee included a multidisciplinary team of experts from various specialties involved in the management of CCA, as well as patient/public representatives from AMMF (the Cholangiocarcinoma Charity) and PSC Support. Quality of evidence is presented using the Appraisal of Guidelines for Research and Evaluation (AGREE II) format. The recommendations arising are to be used as guidance rather than as a strict protocol-based reference, as the management of patients with CCA is often complex and always requires individual patient-centred considerations.Citation
Rushbrook SM, Kendall TJ, Zen Y, Albazaz R, Manoharan P, Pereira SP, et al. British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma. Gut. 2023 Sep 28. PubMed PMID: 37770126. Epub 2023/09/29. eng.Journal
GutDOI
10.1136/gutjnl-2023-330029PubMed ID
37770126Additional Links
https://dx.doi.org/10.1136/gutjnl-2023-330029Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1136/gutjnl-2023-330029